Analysis – Page 2 – Goldea Capital

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitis Expanded pipeline strategy to include cancer cachexia, a serious cancer-associated wasting condition with no FDA-approved therapies specifically indicated for the condition Jericho, New York, May 14, 2026 (GLOBE NEWSWIRE) — Curanex Pharmaceuticals, Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a pharmaceutical development company focused on advancing therapeutic assets for serious diseases with significant unmet medical need, today provided a first quarter 2026 business update highlighting continued progress with Phyto-N, the Company’s lead drug candidate. Curanex is advancing Phyto-N toward a planned Investigational New Drug (“IND”) submission to the U.S. Food and Drug Administration...

LPL Financial Welcomes Fifteen:22 Financial Partners

Written by Customer Service on May 14, 2026. Posted in Public Companies.

SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the financial advisors of Fifteen:22 Financial Partners have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. The team reported serving approximately $380 million in advisory, brokerage and retirement plan assets* and joins LPL from Nations Financial Group. Based in Kansas, Fifteen:22 Financial Partners is comprised of managing partners Douglas Bennett, Nicholas Bennett, Van Schaffer, Malcolm Ong, Brent Hoffman and Douglas Stephens, bringing together more than 120 years of combined industry experience. Founded more than 35 years ago, the firm was built on a legacy of deep client relationships and has grown through multigenerational referrals and a commitment to personalized, long-term financial guidance. Fifteen:22...

Formula Systems Declares a Special Cash Dividend of $200 Million, or $13.045 Per Share, for Year 2025

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Or Yehuda, Israel, May 14, 2026 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced that its board of directors has approved the distribution of a special cash dividend, based on Formula’s results for 2025, including, in particular, the completion of the acquisition of Sapiens by Advent, of $13.045 per share, or approximately $200.0 million in total. The dividend will be paid on June 4, 2026 to all of the Company’s shareholders of record at the close of trading on the Nasdaq Global Select Market (or the Tel-Aviv Stock Exchange, as appropriate) on May 25,...

Sumitomo Forestry Completes Acquisition of Tri Pointe Homes, Creating a Leading U.S. Homebuilder

Written by Customer Service on May 14, 2026. Posted in Mergers And Acquisitions.

Supports expansion of U.S. housing supply while accelerating growth of Tri Pointe Homes’ high-quality operations TOKYO and INCLINE VILLAGE, Nev., May 14, 2026 (GLOBE NEWSWIRE) — Sumitomo Forestry Co., Ltd. (“Sumitomo Forestry”) (TSE: 1911) and Tri Pointe Homes, Inc. (“Tri Pointe Homes”) today announced the successful completion of Sumitomo Forestry’s acquisition of Tri Pointe Homes for US$47.00 per share. With the closing of the transaction, Tri Pointe Homes is now a wholly owned subsidiary of Sumitomo Forestry America, Inc., which is a wholly owned subsidiary of Sumitomo Forestry Group, and will cease trading on the New York Stock Exchange. Through this acquisition, Tri Pointe Homes’ premium lifestyle brand, more than 160 active communities, and operations across 13 high-growth states will be added, making the Sumitomo Forestry...

Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

Secured strategic financing vehicle for up to $40 million Positive FDA feedback supports single-arm pivotal trial for potential registration of SENTI-202 in initial indication of Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Continued operational streamlining contributed to substantially reduced quarterly net loss and cash burn SOUTH SAN FRANCISCO, Calif., May 14, 2026 (GLOBE NEWSWIRE) — Senti Biosciences Holdings, Inc. (Nasdaq: SNTI) (Senti Bio), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the first quarter ended March 31, 2026, and provided recent business highlights. “We entered 2026 with a clear focus on advancing SENTI-202 and extending our operational runway while positioning the company...

Orbit International Corp. Reports 2026 First Quarter Results

Written by Customer Service on May 14, 2026. Posted in Earnings Releases And Operating Results.

First Quarter 2026 Net Loss of $1,546,000 ($0.46 loss per share) v. Net Loss of $2,152,000 ($0.65 loss per share) in Prior Year Comparable Period First Quarter 2026 EBITDA, as adjusted, was a loss of $1,313,000 ($0.39 loss per share) v. loss of $1,949,000 ($0.59 loss per share) in Prior Year Comparable Period Backlog at March 31, 2026 was $13.2 million compared to $12.3 million at December 31, 2025 HAUPPAUGE, N.Y., May 14, 2026 (GLOBE NEWSWIRE) — Orbit International Corp. (OTCID Basic Market:ORBT) today announced results for the first quarter ended March 31, 2026. First Quarter 2026 vs. First Quarter 2025Net sales were $5,245,000, as compared to $4,726,000. Gross margin was 23.3%, as compared to 12.4%. Net loss was $1,546,000 ($0.46 loss per share), as compared to a net loss of $2,152,000 ($0.65 loss per share). Earnings before...

Biogen Completes Acquisition of Apellis Pharmaceuticals

Written by Customer Service on May 14, 2026. Posted in Mergers And Acquisitions.

CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in advancing treatments for serious, complement-driven diseases, is now a wholly owned subsidiary of Biogen. The acquisition adds two best-in-class commercialized products, EMPAVELI® and SYFOVRE®, significantly bolstering Biogen’s near-term growth outlook and accelerating the Company’s expansion into nephrology. Together, the products recorded $689 million in net product revenue in 2025. This transaction will strengthen Biogen’s revenue and EPS growth potential by being accretive to Biogen’s Non-GAAP diluted EPS in 2027 and is expected to materially increase Biogen’s non-GAAP EPS compound annual growth rate (CAGR) through the...

20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026

Written by Customer Service on May 14, 2026. Posted in Public Companies.

GAITHERSBURG, Md., May 14, 2026 (GLOBE NEWSWIRE) — 20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that management will attend the upcoming Sidoti Micro-Cap Virtual Conference. 20/20 BioLabs’ Chief Executive Officer, Jonathan Cohen, will participate in one-on-one investor meetings and host a presentation from 3:15 PM ET to 3:45 PM ET in Track 1. Mr. Cohen will discuss the Company’s recently reported quarterly results, recent partnership and licensing activity, and the plans to scale the OneTest platform. Sidoti Virtual Micro-Cap Virtual Conference Date: Wednesday, May 20, 2026Format: Presentation & Virtual 1×1 MeetingsPresentation: 3:15 – 3:45 PM ET in Track...

Helport AI Launches New ‘AI Labor’ Corporate Website

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Powered by the HyprX Expert Replication Engine to Deliver Real-Time AI-Powered Expert Interaction SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), a global technology company providing enterprise clients with intelligent customer communication software and services powered by artificial intelligence (“AI”), today officially announced the launch of its next-generation AI-powered corporate website (https://www.helport.ai/), marking the commercial rollout of the company’s flagship HyprX Expert Replication Engine and reinforcing the Company’s strategic positioning as a leader in the emerging “AI Labor System” category. Unlike traditional enterprise websites built around static pages, search bars, and delayed customer response workflows, Helport AI’s new engine seeks to transform...

Phunware Appoints Dmitry Kroshka as Chief Executive Officer to Lead 2.0 Strategy; Engages Michael Cerdá to Drive Product Rollout

Written by Customer Service on May 14, 2026. Posted in Public Companies.

Leadership Changes Align Strategy, Product Execution, and Commercial Rollout of Phunware’s Next-Generation Guest Intelligence Platform Company to Accelerate Product 2.0 Strategy Across Hospitality, Healthcare, and Large-Property Environments AI Concierge Momentum, 95%+ Customer Retention, and Strong Cash Position Provide Foundation for Next Phase of Growth AUSTIN, Texas, May 14, 2026 (GLOBE NEWSWIRE) — Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), a mobile-first enterprise cloud platform delivering location-aware customer intelligence and AI-enabled audience engagement tools, today announced a leadership transition and product strategy update designed to accelerate the Company’s 2.0 Strategy and expand its footprint across hospitality, healthcare, and other large-property verticals. Effective immediately, Dmitry...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals